MedTech Software Development: Standards, Tech Stack, and Partner Selection

MedTech software development is the process of building software for medical devices, clinical platforms, and digital health systems, subject to regulatory frameworks such as IEC 62304, ISO 13485, and the FDA Software as a Medical Device (SaMD) classification.

The wrong partner or tech stack choice triggers rework during regulatory verification, extending timelines and increasing costs. This guide covers the regulatory standards that constrain architecture choices, the tech stack decisions that affect IEC 62304 compliance, and the evaluation criteria MedTech development teams use to select a development partner. Atta Systems builds medical device software and digital health platforms across all three IEC 62304 safety classes.

What MedTech software development covers

MedTech software development covers embedded device firmware, standalone Software as a Medical Device (SaMD), clinical decision support systems, remote patient monitoring platforms, and EHR/EMR integrations. Each category has different regulatory classification triggers, development requirements, and architecture constraints.

One critical rule before the categories: if a MedTech development team does not perform safety classification at the start of a project, IEC 62304 defaults the entire software system to Class C. Class C triggers the maximum documentation and testing burden—detailed design documentation, unit-level verification, mandatory code reviews, and static analysis. Skipping classification does not reduce regulatory work; it maximizes it.

The five main categories of MedTech software:

• Embedded medical device firmware controls the operation of physical hardware such as MRI scanners, insulin pumps, and ventilators. This software runs on dedicated processors, requires real-time performance, and is almost always classified as IEC 62304 Class B or C.
• Software as a Medical Device (SaMD) performs a medical function independently of hardware. AI radiology analysis tools, ECG interpretation apps, and clinical risk calculators are SaMD. The FDA, EU MDR, and IMDRF each define SaMD classification criteria differently.
• Clinical decision support (CDS) systems analyze patient data to suggest diagnoses or treatment pathways. Under the 21st Century Cures Act, a CDS tool qualifies for FDA enforcement discretion if it meets four criteria: it does not acquire or analyze an image or signal from an in vitro diagnostic device, it is intended for a healthcare professional, it allows the professional to review the basis of the recommendation independently, and it does not provide a specific treatment recommendation for a specific individual. CDS tools that meet all four criteria are not regulated as medical devices.
• Remote patient monitoring (RPM) platforms collect data from wearable sensors, connected devices, or patient-reported data and transmit it to clinical teams. RPM software that only transmits data without interpretation typically falls outside medical device classification. RPM software that analyzes, interprets, or generates clinical alerts from data crosses into SaMD territory and requires regulatory classification based on the clinical significance of its output.
• EHR/EMR integration software connects clinical systems using interoperability standards such as HL7 FHIR. Integration software that does not perform diagnostic or therapeutic functions may fall outside medical device classification, depending on jurisdiction and intended use.

Regulatory standards that shape MedTech software architecture

MedTech software architecture must satisfy IEC 62304 for the development lifecycle, ISO 13485 for quality management, ISO 14971 for risk management, and FDA 21 CFR Part 820 for design controls when targeting the US market.

Five standards govern how MedTech software is built, tested, and documented:

Standard	Scope	When It Applies	Impact on Architecture
IEC 62304	Medical device software lifecycle processes. Defines safety classes A, B, and C based on potential patient harm.	Required for FDA 510(k) and EU MDR CE marking. Applies to SaMD, embedded firmware, and software components of medical devices.	Determines documentation depth, testing rigor, and design traceability requirements. Class C requires detailed design documentation and unit-level verification.
ISO 13485	Quality management system for medical device organizations.	Required for EU MDR compliance. Expected by the FDA as part of the Quality System Regulation.	Mandates document control, design and development procedures, CAPA processes, and supplier management across the development organization.
ISO 14971	Risk management for medical devices, including software-related hazards.	Required alongside IEC 62304. Applies throughout the software lifecycle from planning through post-market.	Requires documented risk analysis, risk evaluation, risk control implementation, and residual risk assessment for every software function that could contribute to a hazardous situation.
FDA SaMD / 21 CFR 820	US regulatory pathway for software that performs medical functions. 21 CFR 820 covers design controls.	Required for US market entry. FDA documentation levels (Basic/Enhanced) determine submission depth.	Requires design input/output documentation, design reviews, design verification and validation, and design transfer records. The FDA documentation levels do not map directly to IEC 62304 safety classes.
HIPAA	US data protection for Protected Health Information (PHI).	Applies only to covered entities (healthcare providers, health plans, clearinghouses) and their business associates.	Requires encryption, access controls, audit logging, and breach notification for systems that store or transmit PHI. Does not apply to most medical device manufacturers unless they also operate as covered entities.

A common misunderstanding: HIPAA applies to all health software. It does not. HIPAA applies specifically to covered entities and their business associates. Most MedTech device manufacturers are not covered entities unless they also operate as healthcare providers or health plans. A MedTech development team building an insulin pump controller is not automatically subject to HIPAA. A MedTech development team building a patient portal that stores PHI on behalf of a hospital likely is.

Tech stack for MedTech software development

MedTech software tech stacks vary by IEC 62304 safety class. Class A products (no injury risk) can use higher-level languages and cloud-native architectures. Class C products (with a risk of death or serious injury) require deterministic execution, formal verification, and auditable toolchains.

The safety class assigned to a product determines which languages, frameworks, and infrastructure choices are defensible during a regulatory audit:

Safety Class	Typical Languages	Frameworks / Platforms	Testing Requirements	Example Products
Class A	Python, JavaScript/TypeScript, Java, Kotlin, Swift	React Native, Flutter, Node.js, Django, AWS HealthLake, Azure Health Data Services	Software requirements verification. System testing (mandatory since IEC 62304 Amendment 1, 2015). No detailed design documentation required.	Wellness tracking apps, clinical workflow tools, patient scheduling systems, and data display dashboards
Class B	C++, Java, C#, Python (with validated libraries)	Qt Medical, .NET, Spring Boot, FHIR-compliant middleware	Software requirements + architecture verification. Integration testing. Unit testing recommended. SOUP (Software of Unknown Provenance—third-party libraries and components) documentation is mandatory.	PACS DICOM viewers, remote patient monitoring with clinical alerts, and diagnostic imaging processing tools
Class C	C, C++, Ada, Rust (emerging). Formal verification tools for critical paths.	RTOS (FreeRTOS, VxWorks), bare-metal firmware, hardware abstraction layers	Full traceability matrix: requirements → architecture → detailed design → unit implementation → unit verification. Code reviews are mandatory. Static analysis mandatory.	Insulin pump controllers, ventilator firmware, implantable device software, and AI-guided surgical navigation

Integration with hospital systems requires support for HL7 FHIR, the RESTful API standard for healthcare interoperability. FHIR handles patient demographics, clinical observations, medication records, and diagnostic reports in JSON/XML formats. MedTech development teams building EHR-connected products should evaluate FHIR-native platforms (HAPI FHIR, Microsoft FHIR Server, Google Cloud Healthcare API) early in the architecture planning process.

Cloud infrastructure for MedTech software typically runs on AWS HealthLake, Azure Health Data Services, or Google Cloud Healthcare API. All three offer HIPAA-eligible configurations, FHIR-native data stores, and regional compliance controls. The choice depends on existing organizational infrastructure, data residency requirements, and the specific regulatory jurisdiction.

Atta Systems builds Class B and C medical device software using C++ and Python-backed validation pipelines, with CI/CD workflows configured for IEC 62304 traceability from requirements through unit verification.

How to choose a MedTech software development partner

Choosing a MedTech software development partner requires verifying three things: regulatory experience with the target safety class, a documented quality management system aligned to ISO 13485, and domain expertise in the specific clinical workflow the product serves.

Seven evaluation criteria for selecting a MedTech development partner:

1. Regulatory class experience. Ask which IEC 62304 safety classes the partner has completed development cycles for. A partner with only Class A experience will not have the design documentation practices, traceability infrastructure, or testing rigor required for Class B or C.
2. Quality management system. Verify whether the partner maintains an ISO 13485-aligned QMS or operates under a client’s QMS. Ask for their document control procedures and CAPA process. If they cannot produce a software development plan template in accordance with IEC 62304 clause 5.1, they have not made a formal submission.
3. Clinical domain expertise. MedTech software development requires understanding clinical workflows, not just code. A partner building radiology software should understand DICOM, PACS integration, and radiologist reading workflows. Generic software teams without clinical exposure produce technically functional code that clinicians reject.
4. Integration capability. Evaluate whether the partner has built HL7 FHIR integrations, connected to EHR systems, or worked with medical IoT device protocols. Integration failures are the most common cause of MedTech project delays.
5. Cybersecurity practice. FDA guidance requires a cybersecurity risk assessment in premarket submissions. Ask how the partner identifies, analyzes, and controls cybersecurity risks during development. Threat modeling and penetration testing should be documented activities, not afterthoughts.
6. Post-market support capability. IEC 62304 clauses 6 through 9 cover software maintenance, risk management, configuration management, and post-release problem resolution. A partner focused only on initial delivery will leave you without regulatory-compliant post-market support.
7. Engagement model flexibility. MedTech projects vary in scope. Some product teams building Class B or C devices need a full development partner from discovery through regulatory submission. Others need embedded engineers who work within an existing QMS. Evaluate whether the partner offers dedicated squads, team extension, and discovery sprints.

Atta Systems maintains an ISO 13485-aligned QMS and has completed IEC 62304 development cycles across Class B and C safety classifications, with a focus on medical device software and digital health platforms rather than general wellness apps or administrative health tools. Atta Systems offers discovery sprints for MedTech product teams evaluating architecture and regulatory pathway fit before committing to a full development engagement.

In-house MedTech development vs outsourced partner

In-house MedTech software development gives product teams direct control over IP, regulatory submissions, and the quality management system—advantages that matter in regulated environments where ownership of the design history file and risk management process is a long-term responsibility. The trade-off is hiring: recruiting IEC 62304-trained engineers typically takes 4–6 months per senior hire in the current market.

Factor	In-House Team	Outsourced Partner
Time to start	4–6 months to recruit core team. Longer if IEC 62304 experience is required.	2–4 weeks if the partner has capacity and domain expertise available.
Regulatory expertise	Must be built internally or hired. Expensive and scarce.	Available if the partner specializes in MedTech. Verify with past project references.
Cost structure	Fixed salaries, benefits, and tooling. Higher upfront, lower long-term for ongoing products.	Project-based or time-and-materials. Lower upfront, scales with scope.
IP control	Full ownership by default.	Requires clear IP assignment clauses. Standard in MedTech contracts, but must be verified.
Post-market burden	Team handles maintenance, CAPA, and field safety updates directly.	Requires a contractual post-market support agreement. Not all partners offer this.

Red flags when evaluating MedTech software vendors

• Claiming HIPAA compliance without context. If a vendor says “we are HIPAA-compliant” but cannot explain whether they operate as a business associate or a covered entity, they do not understand the regulatory framework.
• No risk management file. ISO 14971 requires a documented risk management file maintained throughout the software lifecycle. If the vendor cannot produce one from a past project (redacted), they have not completed a formal MedTech development cycle.
• No IEC 62304 software development plan. The development plan is clause 5.1 of IEC 62304 and the first deliverable in any compliant project. Its absence means the vendor has not worked under the standard.
• Generic portfolio with no MedTech projects. Software development companies that list MedTech as one of 15 industries served but do not show specific MedTech deliverables (regulatory submissions, safety classification reports, clinical validation results) are unlikely to have the depth required.
• No pre-submission experience. For US market entry, FDA pre-submissions (formerly pre-subs) are critical for de-risking the regulatory pathway before significant development investment. A partner who has never participated in a pre-sub cannot guide you through the most important risk-reduction step.

MedTech software development lifecycle and delivery phases

MedTech software development follows a phased lifecycle, as defined by IEC 62304, including software development planning, requirements analysis, architectural design, detailed design, implementation, integration testing, system testing, and software release.

IEC 62304 organizes the lifecycle into eight activities. The depth of documentation and testing required for each activity depends on the safety class:

1. Software development planning (clause 5.1). Define the development process, tools, methods, standards, and roles. Produce the software development plan. Required for all safety classes.
2. Software requirements analysis (clause 5.2). Document functional requirements, performance requirements, interface requirements, and safety requirements. Trace each requirement to the risk analysis. Required for all safety classes.
3. Software architectural design (clause 5.3). Define the software architecture, including components, interfaces, and data flows. Identify SOUP dependencies. Required for Class B and C.
4. Software detailed design (clause 5.4). Document the design of each software unit in enough detail to enable implementation and verification. Required for Class C only.
5. Software unit implementation and verification (clause 5.5). Write code and verify that each unit meets its detailed design specification. Unit testing, static analysis, and code review are common verification methods. Required for Class C; recommended for Class B.
6. Software integration and integration testing (clause 5.6). Integrate software units and verify that the integrated software meets the architectural design. Required for Class B and C.
7. Software system testing (clause 5.7). Verify that the complete software system meets all software requirements. Mandatory for all safety classes since IEC 62304 Amendment 1 (2015).
8. Software release (clause 5.8). Document the released software version, known anomalies, and release procedures. Archive all development artifacts. Required for all safety classes.

The safety class determines how much of this lifecycle must be formally documented. Class A requires planning, requirements, system testing, and release documentation. Class B adds documentation for architecture and integration testing. Class C adds detailed design and unit verification.

MedTech software, beyond the development lifecycle, must also satisfy security and data protection requirements that vary by jurisdiction and by whether the product handles patient data.

Security, compliance, and data constraints in MedTech software

MedTech software security requirements depend on regulatory jurisdiction, intended use, and data classification. Products that store Protected Health Information (PHI) in the US must comply with HIPAA if the manufacturer is a covered entity or business associate. All products entering the EU market must meet GDPR data protection requirements.

Three frameworks govern MedTech software security:

• HIPAA (US). Applies when the manufacturer is a covered entity or business associate handling PHI. Requires encryption at rest and in transit, access controls, audit logging, breach notification within 60 days, and Business Associate Agreements with subcontractors. Architectural impact: PHI encryption in storage and transit layers, role-based access control, immutable audit logs, and data retention/destruction policies.
• GDPR (EU). Applies to any processing of personal data of EU residents, including special category data such as health data. Requires lawful basis for processing, data minimization, right to erasure, Data Protection Impact Assessment for health data, and 72-hour breach notification. Architectural impact: data residency controls (EU-hosted infrastructure or adequate safeguards), consent management, data portability APIs, and automated deletion workflows.
• FDA Cybersecurity Guidance. Applies to all medical devices with software functions seeking entry into the US market. Requires threat modeling, cybersecurity risk assessment, security architecture documentation, vulnerability disclosure policy, and a software bill of materials (SBOM). Architectural impact: documented threat model as part of premarket submission, SBOM for all software components, and a plan for ongoing vulnerability monitoring.

The FDA’s 2023 cybersecurity guidance (Section 524B of the FD&C Act, effective March 2023) requires a cybersecurity plan in premarket submissions for all cyber devices. This includes a software bill of materials, a plan to address post-market vulnerabilities, and evidence that the device was designed with cybersecurity in mind. MedTech development teams that treat cybersecurity as a post-development add-on will face submission rejections.

Frequently asked questions about MedTech software development

What programming languages are used in MedTech software development?

MedTech software development uses C and C++ for embedded medical device firmware, Python for AI/ML diagnostics and data pipelines, Java and C# for clinical platform backends, and JavaScript/TypeScript for web-based interfaces. The choice depends on the IEC 62304 safety class: Class C embedded systems almost always require C or C++ for deterministic execution. Class A applications can use any modern language with validated libraries.

How long does MedTech software development take?

MedTech software development timelines range from 6–12 months for Class A SaMD products to 18–36 months for Class C embedded device software. Regulatory submissions add 3–12 months, depending on the pathway. FDA 510(k) submissions with a pre-submission strategy typically take 3–6 months to be reviewed. De Novo classifications typically take 6–12 months for FDA review.

What is the difference between SaMD and SiMD?

Software as a Medical Device (SaMD) performs a medical function independently of hardware. An AI radiology analysis tool running on a standard computer is SaMD. Software in a Medical Device (SiMD) is embedded in or controls a physical medical device, such as the controller for an insulin pump or the firmware for an MRI scanner. The distinction matters because SaMD and SiMD follow different regulatory classification pathways.

Does all MedTech software require FDA approval?

Not all MedTech software requires FDA approval. The FDA classifies software based on its intended use and risk level. Clinical decision support tools that only display information for clinicians to independently review—without providing specific treatment recommendations—may qualify for enforcement discretion under the 21st Century Cures Act and skip formal clearance. Wellness and general health apps that do not claim to diagnose, treat, or prevent disease are also outside FDA jurisdiction.

Atta Systems builds MedTech software across IEC 62304 Class B and C safety classifications, from architecture planning through regulatory submission and post-market support.